696 related articles for article (PubMed ID: 20351271)
21. Rapid quantification of glutaminase 2 (GLS2)-related metabolites by HILIC-MS/MS.
Chen GY; Chao HC; Liao HW; Tsai IL; Kuo CH
Anal Biochem; 2017 Dec; 539():39-44. PubMed ID: 28993139
[TBL] [Abstract][Full Text] [Related]
22. Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model.
Mao X; Chen H; Lin AZ; Kim S; Burczynski ME; Na E; Halasz G; Sleeman MW; Murphy AJ; Okamoto H; Cheng X
J Inherit Metab Dis; 2022 May; 45(3):470-480. PubMed ID: 34988999
[TBL] [Abstract][Full Text] [Related]
23. Two Faces of Glutaminase GLS2 in Carcinogenesis.
Buczkowska J; Szeliga M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067269
[TBL] [Abstract][Full Text] [Related]
24. GLS2 is protumorigenic in breast cancers.
Dias MM; Adamoski D; Dos Reis LM; Ascenção CFR; de Oliveira KRS; Mafra ACP; da Silva Bastos AC; Quintero M; de G Cassago C; Ferreira IM; Fidelis CHV; Rocco SA; Bajgelman MC; Stine Z; Berindan-Neagoe I; Calin GA; Ambrosio ALB; Dias SMG
Oncogene; 2020 Jan; 39(3):690-702. PubMed ID: 31541193
[TBL] [Abstract][Full Text] [Related]
25. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.
Luo Y; Li W; Ling Z; Hu Q; Fan Z; Cheng B; Tao X
Cancer Med; 2020 May; 9(10):3489-3499. PubMed ID: 32162845
[TBL] [Abstract][Full Text] [Related]
26. The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists.
Miao Y; Zheng Y; Geng Y; Yang L; Cao N; Dai Y; Wei Z
Theranostics; 2021; 11(9):4531-4548. PubMed ID: 33754076
[No Abstract] [Full Text] [Related]
27. The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.
Yang H; Xiang S; Kazi A; Sebti SM
J Biol Chem; 2020 Mar; 295(10):3055-3063. PubMed ID: 32001619
[TBL] [Abstract][Full Text] [Related]
28. Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation.
López de la Oliva AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Martín-Rufián M; Sialana FJ; Castilla L; Bae N; Lobo C; Peñalver A; García-Frutos M; Carro D; Enrique V; Paz JC; Mirmira RG; Gutiérrez A; Alonso FJ; Segura JA; Matés JM; Lubec G; Márquez J
Sci Rep; 2020 Feb; 10(1):2259. PubMed ID: 32042057
[TBL] [Abstract][Full Text] [Related]
29. Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells.
Kuo TC; Chen CK; Hua KT; Yu P; Lee WJ; Chen MW; Jeng YM; Chien MH; Kuo KT; Hsiao M; Kuo ML
Cancer Lett; 2016 Dec; 383(2):282-294. PubMed ID: 27725225
[TBL] [Abstract][Full Text] [Related]
30. Ionizing Radiation Upregulates Glutamine Metabolism and Induces Cell Death via Accumulation of Reactive Oxygen Species.
Yang P; Luo X; Li J; Zhang T; Gao X; Hua J; Li Y; Ding N; He J; Zhang Y; Wei W; Wang J; Zhou H
Oxid Med Cell Longev; 2021; 2021():5826932. PubMed ID: 35028001
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of glutamine metabolism increases sensitivity to plasma-activated medium-induced cytotoxicity.
Tanaka S; Hayashi S; Otsuka T; Kamiya T; Ishikawa K; Hara H
Free Radic Res; 2024 Mar; 58(3):170-179. PubMed ID: 38511644
[TBL] [Abstract][Full Text] [Related]
32. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species.
Karawajew L; Rhein P; Czerwony G; Ludwig WD
Blood; 2005 Jun; 105(12):4767-75. PubMed ID: 15705792
[TBL] [Abstract][Full Text] [Related]
33. Targeting hepatic glutaminase activity to ameliorate hyperglycemia.
Miller RA; Shi Y; Lu W; Pirman DA; Jatkar A; Blatnik M; Wu H; Cárdenas C; Wan M; Foskett JK; Park JO; Zhang Y; Holland WL; Rabinowitz JD; Birnbaum MJ
Nat Med; 2018 May; 24(4):518-524. PubMed ID: 29578539
[TBL] [Abstract][Full Text] [Related]
34. The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers.
Basheer HA; Elsalem L; Salem A; Tailor A; Hunter K; Afarinkia K
Curr Cancer Drug Targets; 2022; 22(2):169-179. PubMed ID: 34951574
[TBL] [Abstract][Full Text] [Related]
35. Importance of the flux of phosphate across the inner membrane of kidney mitochondria for the activation of glutaminase and the transport of glutamine.
Kovacević Z
Biochim Biophys Acta; 1976 Jun; 430(3):399-412. PubMed ID: 938640
[TBL] [Abstract][Full Text] [Related]
36. Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.
Chen L; Cui H
Int J Mol Sci; 2015 Sep; 16(9):22830-55. PubMed ID: 26402672
[TBL] [Abstract][Full Text] [Related]
37. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
Lee YZ; Yang CW; Chang HY; Hsu HY; Chen IS; Chang HS; Lee CH; Lee JC; Kumar CR; Qiu YQ; Chao YS; Lee SJ
Oncotarget; 2014 Aug; 5(15):6087-101. PubMed ID: 25026281
[TBL] [Abstract][Full Text] [Related]
38. Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism.
Martín-Rufián M; Tosina M; Campos-Sandoval JA; Manzanares E; Lobo C; Segura JA; Alonso FJ; Matés JM; Márquez J
PLoS One; 2012; 7(6):e38380. PubMed ID: 22679499
[TBL] [Abstract][Full Text] [Related]
39. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
[TBL] [Abstract][Full Text] [Related]
40. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
Gao P; Tchernyshyov I; Chang TC; Lee YS; Kita K; Ochi T; Zeller KI; De Marzo AM; Van Eyk JE; Mendell JT; Dang CV
Nature; 2009 Apr; 458(7239):762-5. PubMed ID: 19219026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
